C2RE Private Investor Briefing - Virtual
by CONNECTpreneur Investor Network
THURSDAY, June 11, 11:30 am EDT
Dear Investors,
Opus8 is hosting a private investor briefing with C2RE.
C2RE is fundamentally disrupting the rare earths landscape by introducing a highly scalable platform for next-gen defense tech infrastructure. We are eliminating geopolitical supply chain vulnerabilities through proprietary nanocarbon solutions that replace or optimize critical rare earths.
C2RE's technology is lower-cost and more eco-friendly vs. traditional rare earth mining through a proprietary myco-mining process and modular “factory on wheels” infrastructure designed for rapid deployment.
The briefing will include an overview of the company’s technology, commercialization strategy, licensing model, industry partnerships, and plans to scale pilot operations across multiple resource sites.
Join an exclusive group of deep tech investors for a private briefing on how we are scaling this disruptive, dual-use technology for global market dominance.
Key highlights include:
Proprietary scalable bio-leaching platform
Critical minerals markets: defense, AI infrastructure, semiconductors, and energy technologies
Traction: Partnership and university engagement across domestic and international mining organizations
Licensing and royalty-based revenue model with infrastructure-lite deployment
Focus on rare earth extraction from existing waste materials rather than new mining
Event Details:
Date: June 11
Time: 11:30 am - 12:30 pm
Location: Online via Zoom
For more information about C2RE, visit their website: https://nanocarbonsolutions.com/
Please note that this meeting is for DIRECT and ACTIVE Accredited investors only. All RSVPs must be pre-registered on this site with the investor criteria filled out. All RSVPs are subject to review and approval. We will provide a confirmation email and a calendar invitation after you register.
Request investor materials by contacting Avery North at anorth@opus8.com.
Thanks much and all the best,
Tien Wong
CEO
Opus8, Inc.